ALVEOGENE LIMITED

Active Oxford

Research and experimental development on biotechnology

1 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

ALVEOGENE LIMITED

Research and experimental development on biotechnology

Founded 7 Sept 2022 Active Oxford, England 1 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 13 May 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 21 Oct 2025 Next due 20 Sept 2026 4 months remaining
Net assets £26K £763K 2024 year on year
Total assets £169K £658K 2024 year on year
Total Liabilities £143K £105K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Oxford Science Enterprises 46 Woodstock Road Oxford OX2 6HT England

Website

www.example.com

Full company profile for ALVEOGENE LIMITED (14342459), an active life sciences and medical technology company based in Oxford, England. Incorporated 7 Sept 2022. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

£18.56k

Decreased by £426.39k (-96%)

Net Assets

£26.03k

Decreased by £762.83k (-97%)

Total Liabilities

£143.39k

Increased by £104.73k (+271%)

Turnover

N/A

Employees

1

Debt Ratio

85%

Increased by 80 (+1600%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Sept 2023Seed
Investor 2Sept 2023Seed
Investor 3Sept 2023Seed

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 17,052,739 Shares £3.45m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
31 Jan 20251,700,000£850k£0.5
30 Nov 20231,872,000£936k£0.5
24 Jul 202310,152,739£101.527£0
24 Jul 20233,328,000£1.66m£0.5

Officers

Officers

3 active
Status
David John HipkissDirectorBritishEngland5524 Jul 2023Active
Eric Walter Frederick Wolfgang AltonDirectorBritishUnited Kingdom697 Sept 2022Active
John RiceDirectorAmericanUnited States7624 Jul 2023Active

Shareholders

Shareholders (33)

Imperial College Innovations Limited
26.7%
4,556,024
Harrington Discovery Institute
19.4%
3,300,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Imperial College Innovations Limited

Unknown

Active
Notified 24 Jul 2023
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Group Structure

Group Structure

ALVEOGENE LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Oct 2025Confirmation StatementConfirmation statement made on 6 Sept 2025 with updates
21 Oct 2025Persons With Significant ControlWithdrawal Of A Person With Significant Control Statement
21 Oct 2025Persons With Significant ControlImperial College Innovations Limited notified as a person with significant control
16 Oct 2025OfficersChange to director Professor Eric Walter Frederick Wolfgang Alton on 1 Oct 2022
16 Oct 2025OfficersAppointment of Dr Alistair James Mcdermott as director on 11 Jul 2025
21 Oct 2025 Confirmation Statement

Confirmation statement made on 6 Sept 2025 with updates

21 Oct 2025 Persons With Significant Control

Withdrawal Of A Person With Significant Control Statement

21 Oct 2025 Persons With Significant Control

Imperial College Innovations Limited notified as a person with significant control

16 Oct 2025 Officers

Change to director Professor Eric Walter Frederick Wolfgang Alton on 1 Oct 2022

16 Oct 2025 Officers

Appointment of Dr Alistair James Mcdermott as director on 11 Jul 2025

Recent Activity

Latest Activity

Confirmation statement made on 6 Sept 2025 with updates

6 months ago on 21 Oct 2025

Withdrawal Of A Person With Significant Control Statement

6 months ago on 21 Oct 2025

Imperial College Innovations Limited notified as a person with significant control

6 months ago on 21 Oct 2025

Change to director Professor Eric Walter Frederick Wolfgang Alton on 1 Oct 2022

6 months ago on 16 Oct 2025

Appointment of Dr Alistair James Mcdermott as director on 11 Jul 2025

6 months ago on 16 Oct 2025